India's Ipca Laboratories sinks to 3-yr low after Unichem Lab deal
BENGALURU, April 25 (Reuters) - Shares of Indian pharmaceutical firm Ipca Laboratories IPCA.NS fell as much as 9.1% to a near three-year low on Tuesday, after it agreed to buy a 33.38% stake in Unichem Laboratories UNLB.NS for up to 10.34 billion rupees ($126.3 million). ($1 = 81.8700 Indian rupees) (Reporting by Ashish Chandra in Bengaluru; Editing by Sonia Cheema) ((ashish.chandra@thomsonreuters.com; +91 7982114624;))
Recent news on Unichem Laboratories
See all newsIndia's Unichem Laboratories drops after US FDA inspection ends with five observations
India's Unichem Labs falls after appeal against tax demand rejected
Brief: Unichem Laboratories June-Quarter Consol PAT 414.7 Million Rupees
India's Unichem Laboratories jumps on posting Q1 profit
India's Unichem Laboratories surges in busiest session ever after block deal at premium